UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051474
Receipt number R000058722
Scientific Title Self-Management of Patients with Ulcerative colitis by Fecal Immunochemical Test at Home
Date of disclosure of the study information 2024/01/01
Last modified on 2023/06/28 22:50:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Self-Management of Patients with Ulcerative colitis by Fecal Immunochemical Test at Home

Acronym

Self-Management of UC Patients with Ulcerative colitis using FIT

Scientific Title

Self-Management of Patients with Ulcerative colitis by Fecal Immunochemical Test at Home

Scientific Title:Acronym

Self-Management of UC Patients with Ulcerative colitis using FIT

Region

Japan


Condition

Condition

Ulcerative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Usefulness of Home Fecal Immunochemical Test as a Self-Management Tool for Patients with Ulcerative Colitis in Remission after Reduced Drugs

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relapse rate that required a stronger level of treatment than before the drug reduction

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Fecal Immunochemical test at home

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with ulcerative colitis
Patient is in clinical remission, FIT negative (hemoglobin level in stool <50 ng/mL)
Patients are scheduled to reduce the dosage of one drug.
Patients who are able to obtain written consent for participation in this study after receiving a thorough explanation of the study and after fully understanding the study.
Outpatients

Key exclusion criteria

Difficulty in performing the fecal immunochemical test at home.
Patients who are deemed inappropriate as research subjects by the principal investigator and research coordinator.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Sakiko
Middle name
Last name Hiraoka

Organization

Okayama University Hospital

Division name

Department of Gastroenterology

Zip code

7008558

Address

2-5-1 Shikata-cho, kita-ku, Okayama

TEL

0862357219

Email

sakikoh@cc.okayama-u.ac.jp


Public contact

Name of contact person

1st name Sakiko
Middle name
Last name Hiraoka

Organization

Okayama University

Division name

Department of Gastroenterology

Zip code

7008558

Address

2-5-1Shikata-cho, kita-ku, Okayama

TEL

0862357219

Homepage URL


Email

sakikoh@cc.okayama-u.ac.jp


Sponsor or person

Institute

Okayama University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan society for promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University

Address

Okayama University Ethics Review Committee

Tel

0862356938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 06 Month 28 Day

Date of IRB


Anticipated trial start date

2023 Year 10 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Registration was made prior to application to the Ethics Review Board.
This study will be started after it is approved.


Management information

Registered date

2023 Year 06 Month 28 Day

Last modified on

2023 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058722


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name